An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6

被引:16
作者
Del Fattore, A. [1 ]
Cappariello, A. [1 ]
Capulli, M. [2 ]
Rucci, N. [2 ]
Muraca, M. [1 ]
De Benedetti, F. [1 ]
Teti, A. [2 ]
机构
[1] IRCCS, Bambino Gesu Childrens Hosp, I-00165 Rome, Italy
[2] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy
关键词
Bone loss; IL-6; Inflammatory diseases; Osteoporosis; Osteoprotegerin; JUVENILE RHEUMATOID-ARTHRITIS; PARATHYROID-HORMONE; POSTMENOPAUSAL OSTEOPOROSIS; IDIOPATHIC ARTHRITIS; CHRONIC INFLAMMATION; ANABOLIC RESPONSE; MINERAL DENSITY; TRANSGENIC MICE; CHILDREN; OSTEOPROTEGERIN;
D O I
10.1007/s00198-013-2479-2
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Premature osteoporosis and stunted growth are common complications of childhood chronic inflammatory disease. Presently, no treatment regimens are available for these defects in juvenile diseases. We identified the sequential Fc-OPG/hPTH treatment as an experimental therapy that improves the skeletal growth and prevents the bone loss in a mouse model overexpressing IL-6. Premature osteoporosis and stunted growth are common complications of childhood chronic inflammatory diseases and have a significant impact on patients' quality of life. Presently, no treatment regimens are available for these defects in juvenile diseases. To test a new therapeutic approach, we used growing mice overexpressing the pro-inflammatory cytokine IL-6 (TG), which show a generalized bone loss and stunted growth. Since TG mice present increased bone resorption and impaired bone formation, we tested a combined therapy with the antiresorptive modified osteoprotegerin, Fc-OPG, and the anabolic PTH. We injected TG mice with Fc-OPG once at the 4th day of life and with hPTH(1-34) everyday from the 16th to the 30th day of age. A complete prevention of growth and bone defects was observed in treated mice due to normalization of osteoclast and osteoblast parameters. Re-establishment of normal bone turnover was confirmed by RT-PCR analysis and by in vitro experiments that revealed the full rescue of osteoclast and osteoblast functions. The phenotypic recovery of TG mice was due to the sequential treatment, because TG mice treated with Fc-OPG or hPTH alone showed an increase of body weight, tibia length, and bone volume to intermediate levels between those observed in vehicle-treated WT and TG mice. Our results identified the sequential Fc-OPG/hPTH treatment as an experimental therapy that improves the skeletal growth and prevents the bone loss in IL-6 overexpressing mice, thus providing the proof of principle for a therapeutic approach to correct these defects in juvenile inflammatory diseases.
引用
收藏
页码:681 / 692
页数:12
相关论文
共 41 条
[1]
GROWTH IN STILLS DISEASE [J].
ANSELL, BM ;
BYWATERS, EGL .
ANNALS OF THE RHEUMATIC DISEASES, 1956, 15 (04) :295-319
[2]
Bachrach Laura Keyes, 2007, Endocr Pract, V13, P513
[3]
Effects of inflammation on bone: an update [J].
Baker-LePain, Julie C. ;
Nakamura, Mary C. ;
Lane, Nancy E. .
CURRENT OPINION IN RHEUMATOLOGY, 2011, 23 (04) :389-395
[4]
Benedetti D, 2001, ENDOCRINOLOGY, V142, P4818
[5]
Bilezikian J P, 2005, J Endocrinol Invest, V28, P41
[7]
The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis [J].
Black, DM ;
Greenspan, SL ;
Ensrud, KE ;
Palermo, L ;
McGowan, JA ;
Lang, TF ;
Garnero, P ;
Bouxsein, ML ;
Bilezikian, JP ;
Rosen, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (13) :1207-1215
[8]
Bone disease in pediatric rheumatologic disorders. [J].
Burnham J.M. ;
Leonard M.B. .
Current Rheumatology Reports, 2004, 6 (1) :70-78
[9]
Sustained antiresorptive effects after a single treatment with human recombinant osteoprotegerin (OPG): A pharmacodynamic and pharmacokinetic analysis in rats [J].
Capparelli, C ;
Morony, S ;
Warmington, K ;
Adamu, S ;
Lacey, D ;
Dunstan, CR ;
Stouch, B ;
Martin, S ;
Kostenuik, PJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (05) :852-858
[10]
Abnormalities in skeletal growth in children with juvenile rheumatoid arthritis [J].
Cassidy, JT ;
Hillman, LS .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1997, 23 (03) :499-+